US 11103472
Oral suspensions comprising a non-steroidal anti-inflammatory drug (NSAID)
granted A61KA61K31/19A61K31/192
Quick answer
US patent 11103472 (Oral suspensions comprising a non-steroidal anti-inflammatory drug (NSAID)) held by Infirst Healthcare Limited expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Infirst Healthcare Limited
- Grant date
- Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/19, A61K31/192, A61K31/196, A61K31/215